CA
NZ
UK
AU
IND
US
The GAAP net loss of USD 784.8 million followed a USD 708.4 million operating loss, a swing from USD 443.5 million ofOperating Incomea year earlier. The cause was a one time charge: USD 1.23 billion of acquired in processResearch and Developmentexpense tied to the …
U.S. SUBLOCADE net revenue rose 24% to USD 252 million, driven by dispense unit volume growth of 17%, gross to net benefits and favorable price and mix. Total SUBLOCADE net revenue, including Rest of World, reached USD 267 million. Film and other products grew …
Total income increased 6% from a year earlier, with costs growing about 2% over theTrailing Twelve Monthsand positive operating jaws of more than 4 percentage points. Net core lending rose EUR 11 billion and net core deposits rose EUR 12.1 billion, each equal to …
BRINSUPRI contributed USD 400.1 million, a 29% sequential increase, and Chair and CEO Will Lewis said the product passed USD 1 billion of revenue within its first four full quarters of launch. ARIKAYCE revenue was USD 124.4 million. Cost of product revenues was USD …
On August 2, 2026 the company agreed to be acquired by affiliates ofInvestmentfunds managed by Kohlberg Kravis Roberts for USD 127 per share in cash. Stockholders approved the transaction, the antitrustWaiting Periodended early on September 29, 2026, and the company anticipates closing by the …
In Sustainable Technology Solutions, revenue rose USD 157 million to USD 762 million and adjusted EBITDA increased 15% to USD 147 million. The margin of 19.3% compared with 21.2% a year earlier because of a larger liquefiedNatural Gasjoint venture contribution in the prior period. …
The earnings jump leaned heavily on a USD 89.4 million gain on sale of properties, against USD 3.7 million a year earlier. Interest expense rose to USD 87.7 million from USD 84.3 million, andImpairmentcharges were USD 8.0 million. On an operating basis, FFO of …
Research and development expense reached USD 128.5 million, up from USD 74.1 million. STAT6 external costs were USD 52.0 million versus USD 17.4 million, other external costs were USD 31.0 million, personnel costs were USD 30.3 million and overhead was USD 15.1 million. General …
Chief Executive Officer Eilif Serck-Hanssen said revenue and adjusted EBITDA of USD 147 million both came in above the guidance given three months earlier, helped by favorable currency. The chief financial officer put the currency lift to revenue at USD 29 million and said …
Royalty revenue reached USD 70.3 million versus USD 46.6 million, with growth attributed to the newly acquired XOMAAssetsand to products such as Filspari from Travere Therapeutics and Ohtuvayre from Merck. Captisol sales slipped to USD 7.9 million from USD 10.7 million on customer order …
Please wait processing your request...